Diabetes population in USA has been increased by 15 percent in last two years. The Centers for Disease Control and Prevention reports that the current number of diabetes patients shot up around 24 million. The center also reports that majority of the patients suffer from type 2 diabetes.
It is worthwhile to note that around 8 percent of the diabetic population suffer from type 2 diabetes which is caused by lifestyle factors like obesity and sedentary living.
The Centers for Disease Control and Prevention has shown the results from a collection of data in year 2007.
A quarter of people ages 60 and older had diabetes, the agency said. The number of people worldwide with diabetes will double to 366 million by 2030. The World Health Organization, calls the disease an epidemic.
Most people with diabetes have resistance to insulin, which the body uses to convert blood sugar to energy. The C.D.C. report was its first update of the prevalence of diabetes since 2005, when it reported that about 21 million Americans had the disease.
Source: The New York Times
Filed under Diabetes, NIDDM, Obesity | Tags: Centers for Disease Control and Prevention, Insulin, Obesity, sedentary living., type 2 diabetes, World Health Organization | Comment Below
Related?
Insulin therapy ineffective in genetically type 1 diabetes patients September 24th, 2008 Finland researchers have found that the Insulin therapy is not effective in the infants with genetically type 1 diabetes. Researchers from the University of Turku find that in children with elevated genetic risk, nasal insulin started soon after detection of diabetes-associated autoantibodies had no effect on development of type 1 diabetes.
Drug Cocktail May Reverse DiabetesApril 24th, 2006 Cocktail of the two drugs, the anti-CD3 antibody and proinsulin peptide, developed by scientistsin California, can reverse Type 1 diabetes, which usually starts in childhood and occurs when the immune system turns on itself and attacks the insulin-producing cells of the pancreas. This method which has to date only been tested on animals but each of its constituents is already being tested individually in human clinical trials can give potential end to the daily routine of insulin injections and rigid dietary restrictions suffered by millions throughout the world.
Whole Grain Consumption Reduces Risk of Type 2 DiabetesMay 19th, 2008 A group of researchers recently conducted research work on the impact of whole grain and bran on type 2 diabetes. The association of germ with type 2 diabetes is found not so strong.
Type 2 diabetes likely to effect fertility in young men September 2nd, 2008 A new Indian study reveals that the man with type 2 diabetes (NIDDM) are more in risk to effect their ability to father a child. The University of Buffalo study reveals that the man with type 2 diabetes have significantly low levels of testosterone, can have a critical effect on their quality of life.
Effect Of Ethnicity And Obesity On Insulin Resistance During Late PregnancyMarch 7th, 2006 Asian and South Asian women are at a greater risk of developing gestational diabetes than women of Caucasian heritage, says University of Toronto research. The study, published in The Journal of Clinical Endocrinology & Metabolism, highlights the effect of ethnicity and obesity on insulin resistance during late pregnancy.
British Researchers Found Relation Between Levels Of C-reactive And Type 2 DiabetesAugust 14th, 2008 London researchers have found out that the level of C-reactive protein, a marker for inflammation in the blood can not be responsible for type 2 diabetes in human body. Thus the study has clarified the previous studies that had suggested the link between the two.
Obesity and diabetes double heart failure riskJune 1st, 2009 LONDON - Obesity and type-2 diabetes double the risk of heart failure, already the world's most prevalent chronic cardiovascular disease. John McMurray, professor of cardiology at Western Infirmary, said that a third of patients with heart failure have evidence of diabetes, for whom effective treatment is "very difficult".
AstraZeneca's Oral Drug Onglyza (Saxagliptin) Successful in Type 2 Diabetes Control, May Be Available Soon June 11th, 2008 AstraZeneca, the second largest drug maker in UK is all set to launch its newest product Saxagliptin for late stage diabetes. The drug is to be released in the brand name of Onglyza.
